23Andme Holding Company Insiders
ME Stock | USD 2.23 0.01 0.45% |
23Andme Holding employs about 560 people. The company is managed by 21 executives with a total tenure of roughly 1307 years, averaging almost 62.0 years of service per executive, having 26.67 employees per reported executive. Evaluation of 23Andme Holding's management performance can provide insight into the firm performance.
23Andme |
23Andme Holding Management Team Effectiveness
The company has Return on Asset (ROA) of (0.3318) % which means that for every 100 dollars spent on asset, it generated a loss of $0.3318. This is way below average. Likewise, it shows a return on total equity (ROE) of (1.9376) %, which implies that it produced no returns to current stockholders. 23Andme Holding's management efficiency ratios could be used to measure how well 23Andme Holding manages its routine affairs as well as how well it operates its assets and liabilities.23Andme Holding Workforce Comparison
23Andme Holding Co is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 235,323. 23Andme Holding adds roughly 560 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Net Profit Margin (PM) of (1.87) %, which may indicate that it does not properly execute on its own pricing strategies. This is way below average. Likewise, it shows Net Operating Margin (NOM) of (0.42) %, which signifies that for every 100 dollars of sales, it has a net operating loss of $0.42. 23Andme Holding Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific 23Andme Holding insiders, such as employees or executives, is commonly permitted as long as it does not rely on 23Andme Holding's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, 23Andme Holding insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
23Andme Holding Notable Stakeholders
A 23Andme Holding stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as 23Andme Holding often face trade-offs trying to please all of them. 23Andme Holding's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting 23Andme Holding's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Anne Wojcicki | CEO, CoFounder | Profile | |
Joseph Selsavage | Interim Officer | Profile | |
Frank Russo | Chief Officer | Profile | |
Katie Watson | Vice Communications | Profile | |
MB ChB | Executive Officer | Profile | |
Wade Walke | VP Relations | Profile | |
Jennifer Low | Head Development | Profile | |
JD Esq | Chief Secretary | Profile | |
Kent Hillyer | Vice Operations | Profile | |
Tracy Keim | Chief Officer | Profile | |
Jennifer MD | Head Development | Profile | |
Reza MBA | Chief Officer | Profile | |
Adam Auton | Vice Genetics | Profile | |
Guy Chayoun | Vice Counsel | Profile | |
Jacquie JD | General Officer | Profile | |
Daniel Chu | Chief Officer | Profile | |
Jonathan Ward | Chief Officer | Profile | |
Savita Pillai | Vice People | Profile | |
David Baker | Chief Engineering | Profile | |
William Richards | Head Discovery | Profile | |
Eli Fry | Vice Operations | Profile |
About 23Andme Holding Management Performance
The success or failure of an entity such as 23Andme Holding often depends on how effective the management is. 23Andme Holding management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of 23Andme management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the 23Andme management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
23andMe Holding Co. operates as a consumer genetics testing company. The company was founded in 2006 and is headquartered in South San Francisco, California. 23Andme Holding is traded on NASDAQ Exchange in the United States.
Please note, the presentation of 23Andme Holding's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, 23Andme Holding's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of 23Andme Holding's management manipulating its earnings.
23Andme Holding Workforce Analysis
Traditionally, organizations such as 23Andme Holding use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare 23Andme Holding within its industry.23Andme Holding Manpower Efficiency
Return on 23Andme Holding Manpower
Revenue Per Employee | 392.2K | |
Revenue Per Executive | 10.5M | |
Net Loss Per Employee | 1.2M | |
Net Loss Per Executive | 31.7M | |
Working Capital Per Employee | 228.5K | |
Working Capital Per Executive | 6.1M |
Complementary Tools for 23Andme Stock analysis
When running 23Andme Holding's price analysis, check to measure 23Andme Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 23Andme Holding is operating at the current time. Most of 23Andme Holding's value examination focuses on studying past and present price action to predict the probability of 23Andme Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 23Andme Holding's price. Additionally, you may evaluate how the addition of 23Andme Holding to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |